ERYTECH Pharma (ERYP) Up 40% This Month, What Next?

French biotech ERYTECH Pharma S.A. (ERYP) has gained nearly 40% this month as the Company progresses with its lead product candidate Eryaspase, which is based on its proprietary ERYCAPS platform.

from RTT - Top Story https://ift.tt/39u8Kre
via IFTTT